leuprolide

(redirected from Lupron depot)
Also found in: Dictionary.

leuprolide

 [loo-pro´līd]
a synthetic analogue of gonadotropin-releasing hormone, used in the form of the acetate ester as an antineoplastic agent, treatment for endometriosis, and gonadotropin inhibitor. Administered subcutaneously or intramuscularly.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

leuprolide

(lo͞o′prō-līd′)
n.
A drug that is a synthetic polypeptide analog of naturally occurring gonadotropin-releasing hormone, C29H84N16O12, used in its acetate form to treat advanced prostate cancer.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

leuprolide

Viadur® An analogue of gonadotropin-releasing hormone, which has been used to manage PMS, and block ovarian or testicular hormone production in Pts with hormonally active CA. See PMS.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
(12) Lupron Depot 3.75 m Pg Package Insert, Lake Forest, IL: TAP Pharmaceuticals, Oct.
(13) Lupron Depot 3.75 mg Package Insert, Lake Forest, IL: TAP Pharmaceuticals, Oct.
Jacob Zamstein of Bloomfield, Conn., received $30,000-$40,000 from billings for free doses of Lupron Depot, which he used to treat cancer patients.
attorney's case against TAP Pharmaceutical, patients who took the drug Lupron Depot have filed a separate class action lawsuit in Boston, alleging they were overcharged millions of dollars, the Boston Globe said.
Other suggestions might be use of cyclic progestins for a few months, one course of depot medroxyprogesterone acetate (Depo-Provera), or the use of depot leuprolide acetate (Lupron Depot) until amenorrhea is achieved.
Similar to Lupron Depot but (Synarel) administered intransally instead of by injection.
It brought in some 150 billion yen in sales in the year through March 1998, including 80 billion yen in the United States, where it is sold under the name of Lupron Depot.
(30) Additionally, a study of Lupron Depot, 3.5 mg for 3 months, showed a decrease in mean vertebral trabecular BMD of 2.7% compared with baseline.